Autor:	Ute Deppermann, Susann Theile, Maxim Kebenko, Anne C. Wilke, Hubert Serve, Felicitas Thol, Stefanie Amberg, Vera Schlipfenbacher, Franziska Modemann, Michael Heuser, Melanie Janning, Carsten Bokemeyer, Walter Fiedler, Joerg Chromik, Arnold Ganser, Anne L. Kranich
Rok vydání:	2020
Předmět:	Oncology Chemotherapy medicine.medical_specialty business.industry medicine.medical_treatment Phases of clinical research Hematology Internal medicine Relapsed refractory medicine Cytarabine Idarubicin In patient Myeloid leukaemia business medicine.drug
Zdroj:	British Journal of Haematology. 190
ISSN:	1365-2141 0007-1048
DOI:	10.1111/bjh.16804
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a85909858303188b52c8ea9f2e100636 https://doi.org/10.1111/bjh.16804 Zobrazit plný text záznamu Plný text